| Year |
Citation |
Score |
| 2009 |
Jones DC, Lakatos A, Rogge GA, Kuhar MJ. Regulation of cocaine- and amphetamine-regulated transcript mRNA expression by calcium-mediated signaling in GH3 cells. Neuroscience. 160: 339-47. PMID 19258027 DOI: 10.1016/J.Neuroscience.2009.02.051 |
0.303 |
|
| 2009 |
Rogge GA, Jones DC, Green T, Nestler E, Kuhar MJ. Regulation of CART peptide expression by CREB in the rat nucleus accumbens in vivo. Brain Research. 1251: 42-52. PMID 19046951 DOI: 10.1016/J.Brainres.2008.11.011 |
0.338 |
|
| 2008 |
Jones DC, Miller GW. The effects of environmental neurotoxicants on the dopaminergic system: A possible role in drug addiction. Biochemical Pharmacology. 76: 569-81. PMID 18555207 DOI: 10.1016/J.Bcp.2008.05.010 |
0.311 |
|
| 2008 |
Jones DC, Kuhar MJ. CART receptor binding in primary cell cultures of the rat nucleus accumbens. Synapse (New York, N.Y.). 62: 122-7. PMID 18000808 DOI: 10.1002/Syn.20476 |
0.308 |
|
| 2008 |
Hubert GW, Jones DC, Moffett MC, Rogge G, Kuhar MJ. CART peptides as modulators of dopamine and psychostimulants and interactions with the mesolimbic dopaminergic system. Biochemical Pharmacology. 75: 57-62. PMID 17854774 DOI: 10.1016/J.Bcp.2007.07.028 |
0.353 |
|
| 2007 |
Vicentic A, Jones DC. The CART (cocaine- and amphetamine-regulated transcript) system in appetite and drug addiction. The Journal of Pharmacology and Experimental Therapeutics. 320: 499-506. PMID 16840648 DOI: 10.1124/Jpet.105.091512 |
0.358 |
|
| 2006 |
Jaworski JN, Jones DC. The role of CART in the reward/reinforcing properties of psychostimulants. Peptides. 27: 1993-2004. PMID 16766084 DOI: 10.1016/J.Peptides.2006.03.034 |
0.34 |
|
| 2006 |
Hunter RG, Jones D, Vicentic A, Hue G, Rye D, Kuhar MJ. Regulation of CART mRNA in the rat nucleus accumbens via D3 dopamine receptors. Neuropharmacology. 50: 858-64. PMID 16458333 DOI: 10.1016/J.Neuropharm.2005.12.007 |
0.302 |
|
| 2006 |
Jones DC, Kuhar MJ. Cocaine-amphetamine-regulated transcript expression in the rat nucleus accumbens is regulated by adenylyl cyclase and the cyclic adenosine 5'-monophosphate/protein kinase a second messenger system. The Journal of Pharmacology and Experimental Therapeutics. 317: 454-61. PMID 16322355 DOI: 10.1124/Jpet.105.096123 |
0.343 |
|
| 2005 |
Jones DC, Duvauchelle C, Ikegami A, Olsen CM, Lau SS, de la Torre R, Monks TJ. Serotonergic neurotoxic metabolites of ecstasy identified in rat brain. The Journal of Pharmacology and Experimental Therapeutics. 313: 422-31. PMID 15634943 DOI: 10.1124/Jpet.104.077628 |
0.523 |
|
| 2004 |
Monks TJ, Jones DC, Bai F, Lau SS. The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity. Therapeutic Drug Monitoring. 26: 132-6. PMID 15228153 DOI: 10.1097/00007691-200404000-00008 |
0.48 |
|
| 2004 |
Jones DC, Lau SS, Monks TJ. Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells. The Journal of Pharmacology and Experimental Therapeutics. 311: 298-306. PMID 15169827 DOI: 10.1124/Jpet.104.069260 |
0.442 |
|
| 2001 |
Bai F, Jones DC, Lau SS, Monks TJ. Serotonergic neurotoxicity of 3,4-(±)-methylenedioxyamphetamine and 3,4-(±)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of γ-glutamyl transpeptidase Chemical Research in Toxicology. 14: 863-870. PMID 11453733 DOI: 10.1021/Tx010011L |
0.445 |
|
| 2000 |
Jones DC, Gunasekar PG, Borowitz JL, Isom GE. Dopamine-induced apoptosis is mediated by oxidative stress and is enhanced by cyanide in differentiated PC12 cells Journal of Neurochemistry. 74: 2296-2304. PMID 10820189 DOI: 10.1046/J.1471-4159.2000.0742296.X |
0.316 |
|
| Show low-probability matches. |